On the stock market since 2001, it operates in the everyday-essentials business. It has 91,000 employees. Now — the numbers.
This is an established company with proven profits.
The biggest line carries real weight, but it doesn’t decide everything on its own.
Average growth of 8% a year over the last 4 years. Every year shown ended in profit.
The gap is $20.3B. In times of high interest rates, a gap like that can squeeze a company.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit indicators sit around the sector average.
A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.
Clearly below the class average.
This grade is a blend: the profit side is strong, the sales tempo slow.
Clearly above the class average — a step short of the very top.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
The stock trades 18% below its peak. The market has trimmed its expectations for the company.
It met or beat analyst expectations in 7 of the last 8 quarters — consistency is a promise kept.
Over the last 12 months, company executives reported 40 buys and 16 sells. Management buying with its own money is usually read as a good sign.
It pays out $2.00 per share each year — regular cash for whoever holds the stock.
The company’s market value is 33 times its annual profit. Even a small disappointment could hit the price hard.
Today’s price already includes part of tomorrow’s optimism. Report-card grade: 41/100.
On our five-subject report card, MDLZ sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: MDLZ is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.